Concepedia

Lothar Seefried

LS

Statistics

Publications

46

Citations

2.1K

H-Index

26

Active since

2009

Affiliations

University of Würzburg(Current)

Alexion Pharmaceuticals (United States)

Duke Medical Center

Assistance Publique – Hôpitaux de Paris

Vanderbilt University Medical Center

Lothar Seefried is an author at University of Würzburg specializing in medicine, bone metabolism, and bone metabolism disorders.

ORCID

Publications per year

2009–2024

46

Publications

46

The Transcriptional Profile of Mesenchymal Stem Cell Populations in Primary Osteoporosis Is Distinct and Shows Overexpression of Osteogenic Inhibitors

Peggy Benisch, Tatjana Schilling, Ludger Klein‐Hitpaß et al. · PLoS ONE · 2012 · 207 citations · Full text

, , +13

BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial

Francis H. Glorieux, Jean‐Pierre Devogelaer, Michaela Durigova et al. · Journal of Bone and Mineral Research · 2017 · 143 citations · Full text

, , +16

Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry

Wolfgang Högler, Craig B. Langman, Hugo Gomes da Silva et al. · BMC Musculoskeletal Disorders · 2019 · 128 citations · Full text

, , +13

BMP12 and BMP13 gene transfer induce ligamentogenic differentiation in mesenchymal progenitor and anterior cruciate ligament cells

Meike Haddad‐Weber, Patrick Prager, Manuela Kunz et al. · Cytotherapy · 2010 · 88 citations · Full text

, , +14

Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry

Lothar Seefried, Kathryn Dahir, Anna Petryk et al. · Journal of Bone and Mineral Research · 2020 · 87 citations · Full text

, , +16

1–5 of 46